Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy
about
Is there clinical value to prognostic signatures in early-stage NSCLC?Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupHigh expression of CASK correlates with progression and poor prognosis of colorectal cancer.Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK.Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients.The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis.
P2860
Q28384571-338EDB0C-B7D6-48ED-BBF3-EDF8CB5C4D0DQ33587905-0BCB48BB-C9CE-48FC-A252-ED88D17F15F1Q34424691-475F0AC0-E4EA-46C7-85D3-50841B346EF9Q34956620-C8E00226-E948-408D-ACE8-6DBAF71C8FF3Q35061368-5307E20C-3094-4115-9621-E7A2D7B99F74Q35095549-B28E6EF7-84F6-4E31-8F20-10CCF6A2D916Q36401886-8951B282-3071-4B14-99A4-B28713322A48Q36542415-BA0CB3E6-770A-47D5-BD97-6A2066A120ACQ38323055-B11A3FD9-6D7C-47B4-9EC4-D23BF054AF49Q38915283-3E78B454-6394-4FBA-8CD3-7E5CF63C768BQ40442754-37D683E8-444A-452C-90D9-E3E192FD3AE4Q49406198-3FDB8E0D-449E-4B3D-9B6C-1DA4A3874C6EQ52620420-90D05400-EB51-4BB0-8153-BA6D8BFE88DE
P2860
Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prediction of survival in rese ...... ed chemoprevention and therapy
@ast
Prediction of survival in rese ...... ed chemoprevention and therapy
@en
type
label
Prediction of survival in rese ...... ed chemoprevention and therapy
@ast
Prediction of survival in rese ...... ed chemoprevention and therapy
@en
prefLabel
Prediction of survival in rese ...... ed chemoprevention and therapy
@ast
Prediction of survival in rese ...... ed chemoprevention and therapy
@en
P2093
P2860
P1476
Prediction of survival in rese ...... ed chemoprevention and therapy
@en
P2093
Carmen Behrens
David C Rice
Diane D Liu
Edward S Kim
Humam Kadara
J Jack Lee
Kathryn A Gold
Luisa M Solis
Stephen G Swisher
P2860
P304
P356
10.1158/1078-0432.CCR-13-1959
P407
P577
2013-12-23T00:00:00Z